Evercore ISI analyst Vijay Kumar raised the firm’s price target on Intuitive Surgical to $240 from $215 and keeps an In Line rating on the shares, which were also added to the firm’s "Tactical Underperform" list as the firm made a number of changes to its lists as part of its Q1 earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ISRG:
- Intuitive Surgical assumed with a Neutral at UBS
- Intuitive Surgical initiated with a Neutral at UBS
- Evercore says Intuitive Surgical outperformance tied to new system speculation
- Prescription for Profit: 3 “Strong Buy” Healthcare Stocks Analysts Love
- William Blair starts Intuitive Surgical at Outperform on favorable risk/reward